Low-level exposure to lead and atherosclerosis in the carotid arteries: Results from the Swedish population-based cohort SCAPIS.

Atherosclerosis Cardiovascular disease Environmental epidemiology Ischaemic stroke Lead Plaque

Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
11 Dec 2023
Historique:
received: 06 09 2023
revised: 20 11 2023
accepted: 07 12 2023
medline: 14 12 2023
pubmed: 14 12 2023
entrez: 13 12 2023
Statut: aheadofprint

Résumé

Lead exposure is associated with cardiovascular disease. Atherosclerosis has been hypothesized to be one of the underlying mechanisms behind this association. To investigate whether lead exposure is associated with an increased risk of atherosclerosis in the carotid arteries in a large Swedish population-based cohort. We performed a cross-sectional study using data from the population-based Swedish CardioPulmonary bioImage Study (SCAPIS), including 5622 middle-aged men and women, enrolled 2013-2018. Blood lead (B-Pb), measured by inductively coupled plasma mass spectrometry, was used as exposure biomarker. The presence of atherosclerotic plaque in the carotid arteries (yes/no), total plaque area (mm Atherosclerotic plaque was present in 57% of the individuals, for whom the median total plaque area was 16 mm This study shows an association between B-Pb and atherosclerosis in the carotid arteries providing some support for the hypothesis that atherosclerosis is one of the mechanisms underlying the association between lead exposure and cardiovascular disease.

Sections du résumé

BACKGROUND BACKGROUND
Lead exposure is associated with cardiovascular disease. Atherosclerosis has been hypothesized to be one of the underlying mechanisms behind this association.
AIM OBJECTIVE
To investigate whether lead exposure is associated with an increased risk of atherosclerosis in the carotid arteries in a large Swedish population-based cohort.
METHODS METHODS
We performed a cross-sectional study using data from the population-based Swedish CardioPulmonary bioImage Study (SCAPIS), including 5622 middle-aged men and women, enrolled 2013-2018. Blood lead (B-Pb), measured by inductively coupled plasma mass spectrometry, was used as exposure biomarker. The presence of atherosclerotic plaque in the carotid arteries (yes/no), total plaque area (mm
RESULTS RESULTS
Atherosclerotic plaque was present in 57% of the individuals, for whom the median total plaque area was 16 mm
CONCLUSIONS CONCLUSIONS
This study shows an association between B-Pb and atherosclerosis in the carotid arteries providing some support for the hypothesis that atherosclerosis is one of the mechanisms underlying the association between lead exposure and cardiovascular disease.

Identifiants

pubmed: 38092241
pii: S0013-9351(23)02704-4
doi: 10.1016/j.envres.2023.117900
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117900

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Carl Guldbrand (C)

Occupational and Environmental Medicine, Sahlgrenska University Hospital and University of Gothenburg, Gothenburg, Sweden.

Lars Barregard (L)

Occupational and Environmental Medicine, Sahlgrenska University Hospital and University of Gothenburg, Gothenburg, Sweden.

Gerd Sallsten (G)

Occupational and Environmental Medicine, Sahlgrenska University Hospital and University of Gothenburg, Gothenburg, Sweden.

Niklas Forsgard (N)

Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.

Thomas Lundh (T)

Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, Lund University, Sweden.

Yan Borné (Y)

Department of Clinical Sciences in Malmö, Lund University, Sweden.

Björn Fagerberg (B)

Department of Molecular and Clinical Medicine, Wallenberg Laboratory for Cardiovascular and Metabolic Research, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.

Gunnar Engström (G)

Department of Clinical Sciences in Malmö, Lund University, Sweden.

Göran Bergström (G)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Florencia Harari (F)

Occupational and Environmental Medicine, Sahlgrenska University Hospital and University of Gothenburg, Gothenburg, Sweden. Electronic address: florencia.harari@amm.gu.se.

Classifications MeSH